Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
The National Cancer Institute-sponsored study collecting malignant ascites, pleural fluid, and blood from people with solid tumors has been …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update comparing platinum-based therapy with dostarlimab (TSR-042) and niraparib versus standard platinum-based therapy as fir…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 [Phase 1]
Phase 1 study of RP903 conducted by Risen (Suzhou) Pharma Tech Co., Ltd. has completed, evaluating safety, tolerability, pharmacokinetics, e…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer [Phase 2]
The EWOC-1 Phase 2 trial evaluating carboplatin with or without paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and tolerability of intraperitoneal nivolumab after extensive debulking surgery and HIPEC in …
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial evaluating adding ipatasertib to paclitaxel and carboplatin for Stage III/IV ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Spectroscopy in Ovarian Cancer
The University of Exeter conducted a completed clinical trial evaluating spectroscopy techniques in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer [Phase 1]
Phase 1 study evaluating carboplatin and paclitaxel chemotherapy with nivolumab, with or without ipilimumab, in ovarian cancer including hig…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study [EARLY_Phase 1]
A completed early-phase feasibility trial evaluating indocyanine green–enabled mapping of ovarian sentinel lymph nodes in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients [Phase 2]
Phase 2 clinical trial evaluating Avutometinib plus Defactinib in Japanese patients with recurrent low-grade serous ovarian cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment [Phase 2]
Phase 2 clinical trial evaluating disitamab vedotin plus carboplatin as first-line treatment for advanced ovarian cancer; the study is curre…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]
Phase 2 clinical trial update for Nirogacestat in ovarian granulosa cell tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating Zafirlukast for marker-relapsed ovarian cancer has completed, with results posted. The study was sponsored…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics [NA]
A clinical trial update for the HOPE-Genomics intervention aimed at improving cancer patients' knowledge of genomics, with results posted on…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of autologous T cells engineered to target the follicle-stimulating hormone receptor (FSHR) for r…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
This completed feasibility trial evaluated saliva-based and remote monitoring approaches for detecting active cytomegalovirus infection and …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]
Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with th…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated immunotherapy with neo-adjuvant chemotherapy for ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. [Phase 2, Phase 3]
Phase 2/3 DETERMINE trial treatment arm 05 is evaluating the combination of vemurafenib and cobimetinib in adults with BRAF-positive cancers…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of Serum Folate Levels in Patients Treated With Olaparib [Phase 4]
Phase 4 trial evaluating serum folate levels in patients with ovarian or breast cancer treated with olaparib; results are now posted.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating REGN5668 with cemiplimab, cemiplimab plus fianlimab, or ubamatamab in adult women with ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) [NA]
This clinical trial update notes a completed study evaluating an automated system to culture metastatic circulating tumor cells in embryonat…